| pubmed-article:8942881 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8942881 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:8942881 | lifeskim:mentions | umls-concept:C0521009 | lld:lifeskim |
| pubmed-article:8942881 | lifeskim:mentions | umls-concept:C0010043 | lld:lifeskim |
| pubmed-article:8942881 | lifeskim:mentions | umls-concept:C0022568 | lld:lifeskim |
| pubmed-article:8942881 | lifeskim:mentions | umls-concept:C0008809 | lld:lifeskim |
| pubmed-article:8942881 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:8942881 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
| pubmed-article:8942881 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:8942881 | lifeskim:mentions | umls-concept:C1250374 | lld:lifeskim |
| pubmed-article:8942881 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:8942881 | pubmed:dateCreated | 1996-12-20 | lld:pubmed |
| pubmed-article:8942881 | pubmed:abstractText | The purpose of the study is to compare the clinical efficacy and safety of ciprofloxacin ophthalmic solution 0.3% (Ciloxan) with a standard therapy regimen (fortified tobramycin, 1.3%-cefazolin, 5.0%) for treating bacterial corneal ulcers. | lld:pubmed |
| pubmed-article:8942881 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8942881 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8942881 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8942881 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8942881 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8942881 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8942881 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8942881 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8942881 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8942881 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8942881 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8942881 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:8942881 | pubmed:issn | 0161-6420 | lld:pubmed |
| pubmed-article:8942881 | pubmed:author | pubmed-author:ReddyM KMK | lld:pubmed |
| pubmed-article:8942881 | pubmed:author | pubmed-author:LEVYJ PJP | lld:pubmed |
| pubmed-article:8942881 | pubmed:author | pubmed-author:CaldwellD RDR | lld:pubmed |
| pubmed-article:8942881 | pubmed:author | pubmed-author:EifermanR ARA | lld:pubmed |
| pubmed-article:8942881 | pubmed:author | pubmed-author:HyndiukR ARA | lld:pubmed |
| pubmed-article:8942881 | pubmed:author | pubmed-author:AdenisJ PJP | lld:pubmed |
| pubmed-article:8942881 | pubmed:author | pubmed-author:BadrinathS... | lld:pubmed |
| pubmed-article:8942881 | pubmed:author | pubmed-author:KlaussVV | lld:pubmed |
| pubmed-article:8942881 | pubmed:author | pubmed-author:RosenwasserG... | lld:pubmed |
| pubmed-article:8942881 | pubmed:author | pubmed-author:SantosC ICI | lld:pubmed |
| pubmed-article:8942881 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8942881 | pubmed:volume | 103 | lld:pubmed |
| pubmed-article:8942881 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8942881 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8942881 | pubmed:pagination | 1854-62; discussion 1862-3 | lld:pubmed |
| pubmed-article:8942881 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:meshHeading | pubmed-meshheading:8942881-... | lld:pubmed |
| pubmed-article:8942881 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8942881 | pubmed:articleTitle | Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. | lld:pubmed |
| pubmed-article:8942881 | pubmed:affiliation | Medical College of Wisconsin, Milwaukee, USA. | lld:pubmed |
| pubmed-article:8942881 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8942881 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8942881 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8942881 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8942881 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:8942881 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8942881 | lld:pubmed |
